Isotretinoin as a promising option in the treatment of facial papules of frontal fibrosing alopecia

Author:

Beyzaee Amir Mohammad1ORCID,Babaei Mahsa2,Ghoreishi Bahare3,Waśkiel‐Burnat Anna4ORCID,Rudnicka Lidia4,Starace Michela5,Tosti Antonella6,Patil Anant7,Sinclair Rodney8ORCID,Goldust Mohamad9ORCID,Rahmatpour Rokni Ghasem10

Affiliation:

1. Department of Dermatology Mazandaran University of Medical Sciences Sari Iran

2. Shahid Beheshti University of Medical Sciences Tehran Iran

3. Mazandaran University of Medical Sciences Sari Iran

4. Department of Dermatology Medical University of Warsaw Warsaw Poland

5. Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine University of Bologna Bologna Italy

6. Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine Miami Florida USA

7. Department of Pharmacology Dr. DY Patil Medical College Navi Mumbai India

8. Department of Dermatology University of Melbourne Melbourne Vic. Australia

9. Department of Dermatology Yale School of Medicine Yale University New Haven CT USA

10. Faculty of Medicine Department of Dermatology Mazandaran University of Medical Sciences Sari Iran

Abstract

AbstractFrontal fibrosing alopecia (FFA) is a primary cicatricial alopecia characterized by hairline recession, pruritus, and facial papules (FP). Various therapies are used to stabilize disease activity and induce remission. However, FP of FFA is resistant to treatment in many cases. In this review, we searched the PubMed and Google Scholar databases to screen the published literature on treatment options for FP in the context of FFA. Overall, 12 studies were included in this review. Available literature suggests a noticeable improvement in resistant‐to‐treatment FP in FFA patients with oral isotretinoin. The available evidence is limited and is derived from retrospective studies and case reports/series. Systemic isotretinoin can be considered a promising therapeutic regimen for treating resistant‐to‐treatment FP of FFA patients. However, more extensive, well‐designed studies are necessary for confirmatory evidence.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3